These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 26960193)

  • 1. Glucose Augments Killing Efficiency of Daptomycin Challenged Staphylococcus aureus Persisters.
    Prax M; Mechler L; Weidenmaier C; Bertram R
    PLoS One; 2016; 11(3):e0150907. PubMed ID: 26960193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staphylococcus aureus persisters tolerant to bactericidal antibiotics.
    Lechner S; Lewis K; Bertram R
    J Mol Microbiol Biotechnol; 2012; 22(4):235-44. PubMed ID: 22986269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial mechanism of daptomycin antibiotic against Staphylococcus aureus based on a quantitative bacterial proteome analysis.
    Ma W; Zhang D; Li G; Liu J; He G; Zhang P; Yang L; Zhu H; Xu N; Liang S
    J Proteomics; 2017 Jan; 150():242-251. PubMed ID: 27693894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic and transcriptional activities of Staphylococcus aureus challenged with high-doses of daptomycin.
    Lechner S; Prax M; Lange B; Huber C; Eisenreich W; Herbig A; Nieselt K; Bertram R
    Int J Med Microbiol; 2014 Nov; 304(8):931-40. PubMed ID: 24980509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to daptomycin and vancomycin in an in vitro dynamic model.
    Firsov AA; Smirnova MV; Lubenko IY; Vostrov SN; Portnoy YA; Zinner SH
    J Antimicrob Chemother; 2006 Dec; 58(6):1185-92. PubMed ID: 17028094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interplay between population dynamics and drug tolerance of Staphylococcus aureus persister cells.
    Lechner S; Patra P; Klumpp S; Bertram R
    J Mol Microbiol Biotechnol; 2012; 22(6):381-91. PubMed ID: 23363876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concentration-response relationships as a basis for choice of the optimal endpoints of the antimicrobial effect: daptomycin and vancomycin pharmacodynamics with staphylococci in an in vitro dynamic model.
    Smirnova MV; Lubenko IY; Portnoy YA; Zinner SH; Firsov AA
    Int J Antimicrob Agents; 2007 Feb; 29(2):165-9. PubMed ID: 17207607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daptomycin in Combination with Ceftolozane-Tazobactam or Cefazolin against Daptomycin-Susceptible and -Nonsusceptible Staphylococcus aureus in an In Vitro, Hollow-Fiber Model.
    Smith JR; Arya A; Yim J; Barber KE; Hallesy J; Singh NB; Rybak MJ
    Antimicrob Agents Chemother; 2016 Jul; 60(7):3970-5. PubMed ID: 27090172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic and genotypic correlates of daptomycin-resistant methicillin-susceptible Staphylococcus aureus clinical isolates.
    Kang KM; Mishra NN; Park KT; Lee GY; Park YH; Bayer AS; Yang SJ
    J Microbiol; 2017 Feb; 55(2):153-159. PubMed ID: 28120188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of in-vitro-selected daptomycin-non-susceptibility in Staphylococcus aureus.
    Patel D; Husain M; Vidaillac C; Steed ME; Rybak MJ; Seo SM; Kaatz GW
    Int J Antimicrob Agents; 2011 Nov; 38(5):442-6. PubMed ID: 21840181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of daptomycin resistance on Staphylococcus aureus virulence.
    Cameron DR; Mortin LI; Rubio A; Mylonakis E; Moellering RC; Eliopoulos GM; Peleg AY
    Virulence; 2015; 6(2):127-31. PubMed ID: 25830650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo development of daptomycin resistance in vancomycin-susceptible methicillin-resistant Staphylococcus aureus severe infections previously treated with glycopeptides.
    Capone A; Cafiso V; Campanile F; Parisi G; Mariani B; Petrosillo N; Stefani S
    Eur J Clin Microbiol Infect Dis; 2016 Apr; 35(4):625-31. PubMed ID: 26815434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Clinical Isolates Among Daptomycin-Naive Patients in Korea.
    Nam EY; Yang SJ; Kim ES; Cho JE; Park KH; Jung SI; Yoon N; Kim DM; Lee CS; Jang HC; Park Y; Lee KS; Kwak YG; Lee JH; Park SY; Hwang JH; Kim M; Song KH; Kim HB
    Microb Drug Resist; 2018 Jun; 24(5):534-541. PubMed ID: 29863982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of daptomycin alone and in combination with rifampin and gentamicin against Staphylococcus aureus assessed by time-kill methodology.
    Credito K; Lin G; Appelbaum PC
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1504-7. PubMed ID: 17220402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel point mutation promotes growth phase-dependent daptomycin tolerance in Staphylococcus aureus.
    Mechler L; Herbig A; Paprotka K; Fraunholz M; Nieselt K; Bertram R
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5366-76. PubMed ID: 26100694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential daptomycin resistance development in Staphylococcus aureus strains with active and mutated gra regulatory systems.
    Müller A; Grein F; Otto A; Gries K; Orlov D; Zarubaev V; Girard M; Sher X; Shamova O; Roemer T; François P; Becher D; Schneider T; Sahl HG
    Int J Med Microbiol; 2018 Apr; 308(3):335-348. PubMed ID: 29429584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of daptomycin-nonsusceptible strains using the Neo-Sensitab prediffusion method.
    Katz BD; Luperchio SA; Thorne GM
    Diagn Microbiol Infect Dis; 2008 Jul; 61(3):315-20. PubMed ID: 18339508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin.
    Sakoulas G; Alder J; Thauvin-Eliopoulos C; Moellering RC; Eliopoulos GM
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1581-5. PubMed ID: 16569891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of vancomycin and daptomycin against Staphylococcus aureus isolates collected over 29 years.
    Appleman MD; Citron DM
    Diagn Microbiol Infect Dis; 2010 Apr; 66(4):441-4. PubMed ID: 20226335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daptomycin Tolerance in the Staphylococcus aureus pitA6 Mutant Is Due to Upregulation of the dlt Operon.
    Mechler L; Bonetti EJ; Reichert S; Flötenmeyer M; Schrenzel J; Bertram R; François P; Götz F
    Antimicrob Agents Chemother; 2016 May; 60(5):2684-91. PubMed ID: 26883712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.